RICHARD HELLANDER: Open Payments
NPI 1003846932 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 14 payments from 9 companies in 2025. Trend: 2023 $776 · 2024 $788 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 3 | $153 |
| Alkermes, Inc. | 2 | $142 |
| Abbott Laboratories | 2 | $113 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Medtronic, Inc. | 1 | $15 |
Products named: BRIXADI, VIVITROL, FREESTYLE LIBRE 3, SHINGRIX, GARDASIL 9, CAPLYTA, JARDIANCE, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
